$10.06 Million in Sales Expected for Sharps Compliance Corp. (SMED) This Quarter

Analysts expect that Sharps Compliance Corp. (NASDAQ:SMED) will announce $10.06 million in sales for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Sharps Compliance’s earnings, with estimates ranging from $9.38 million to $10.50 million. Sharps Compliance posted sales of $9.68 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 3.9%. The business is scheduled to issue its next quarterly earnings results before the market opens on Wednesday, October 24th.

According to Zacks, analysts expect that Sharps Compliance will report full year sales of $43.11 million for the current fiscal year, with estimates ranging from $42.12 million to $44.90 million. For the next financial year, analysts forecast that the company will post sales of $44.56 million, with estimates ranging from $44.42 million to $44.70 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover Sharps Compliance.

Sharps Compliance (NASDAQ:SMED) last released its earnings results on Tuesday, August 14th. The industrial products company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.04). Sharps Compliance had a negative net margin of 1.67% and a negative return on equity of 2.62%. The business had revenue of $9.91 million during the quarter, compared to analyst estimates of $11.24 million.

A number of research analysts have recently weighed in on SMED shares. Zacks Investment Research cut Sharps Compliance from a “hold” rating to a “strong sell” rating in a research report on Thursday, September 6th. TheStreet cut Sharps Compliance from a “c-” rating to a “d+” rating in a research report on Wednesday, June 27th.

Sharps Compliance stock traded down $0.06 during midday trading on Monday, reaching $3.52. The company’s stock had a trading volume of 1,310 shares, compared to its average volume of 27,393. Sharps Compliance has a fifty-two week low of $3.02 and a fifty-two week high of $5.15. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.05 and a current ratio of 2.71. The company has a market cap of $55.48 million, a P/E ratio of -89.25, a price-to-earnings-growth ratio of 1.30 and a beta of 0.50.

Several hedge funds have recently made changes to their positions in the company. North Star Investment Management Corp. increased its position in shares of Sharps Compliance by 10.0% in the third quarter. North Star Investment Management Corp. now owns 260,425 shares of the industrial products company’s stock valued at $898,000 after buying an additional 23,775 shares in the last quarter. Quantum Capital Management increased its position in Sharps Compliance by 78.4% during the 2nd quarter. Quantum Capital Management now owns 265,105 shares of the industrial products company’s stock worth $978,000 after purchasing an additional 116,512 shares in the last quarter. Finally, Wells Fargo & Company MN increased its position in Sharps Compliance by 59.6% during the 1st quarter. Wells Fargo & Company MN now owns 227,500 shares of the industrial products company’s stock worth $1,033,000 after purchasing an additional 85,000 shares in the last quarter. Institutional investors and hedge funds own 22.85% of the company’s stock.

About Sharps Compliance

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.

See Also: Trading Strategy Methods for Individual Investors

Get a free copy of the Zacks research report on Sharps Compliance (SMED)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sharps Compliance (NASDAQ:SMED)

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply